Healthcare | December 22, 2025
Care ADHD opens its first Global Capability Centre in India
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
The approval for Exdensur (depemokimab-ulaa) comes on the back of SWIFT-1 and SWIFT-2 Phase III trials
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
,_Thyrocare_256_384.jpg)
Dr Kinha is a seasoned healthcare and diagnostics leader with over 17 years of experience across leading organisations in the diagnostics sector, with deep expertise in laboratory operations and quality systems
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
The update promises to revolutionize laboratory workflows by optimizing resources
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
GS-098, a first-in-class, humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor, is designed to rapidly block the pathogenic activity of thyroid-stimulating autoantibodies
Subscribe To Our Newsletter & Stay Updated
